Drug intelligence / Profile preview

ERr 731

Development stage
Unknown
Lead developer
Chemisch-Pharmazeutische Fabrik Göppingen
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

ERr 731 is a standardized extract of the root of *Rheum rhaponticum* (Siberian rhubarb), developed as a nonhormonal therapy primarily for the relief of menopausal symptoms—particularly hot flashes, night sweats, anxiety, mood disturbances, and related symptoms. ERr 731 has been used in Europe since the 1990s and has an established safety profile supported by clinical trials and postmarketing surveillance. Its principal mechanism of action is selective agonism of the estrogen receptor beta (ERβ), without significant activation of estrogen receptor alpha (ERα), resulting in relief of menopausal symptoms without the risks typically associated with conventional hormone therapies. The extract is contraindicated in individuals with known or suspected estrogen-dependent cancers. ERr 731 is distributed under various trade names in Europe and North America and is available as a nonprescription product in multiple countries[1][2][3][4][5].

Brand names
Phytoestrol Nfemi-logesEstrovera
Other names
Siberian rhubarb extractRheum rhaponticum extract
02

Targets

ESR1 (ERα)ESR2 (ERβ)

Beyond the preview

Go deeper on ERr 731.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ERr 731.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call